<DOC>
	<DOCNO>NCT00527319</DOCNO>
	<brief_summary>Cachexia presentation chronic manifestation acute metabolic stress , hypercatabolic nutritional state normal fat protein spar mechanisms functioning increase nutrition utilized . To switch nutritional system hypercatabolic normal nutritional state , therapy must block multi-factorial stress signal threshold activation . Consistent synergistic hypothesis , propranolol etodolac evaluate subject advanced cancer demonstrate cachexia . This trial evaluate safety efficacy VT-122 subject NSCLC hypercatabolic cachexia .</brief_summary>
	<brief_title>Regimen Treatment Cachexia Subjects With NSCLC</brief_title>
	<detailed_description>The objective trial evaluate safety dose tolerability VT-122 regimen evaluate efficacy VT-122 regimen This trial conduct patient diagnosis Stage IV NSCLC , chemotherapy , lose 5 % body weight previous 2 month deem hypercatabolic .</detailed_description>
	<mesh_term>Cachexia</mesh_term>
	<criteria>Subjects NSCLC Demonstrating average weight loss 5 % within 2 month prior enrollment Heart rate 72 bpm great Negative pregnancy test ( female patient child bear age ) Able give inform consent Able administer medication Able take food define nutritional support Have betablockers minimum 1 week prior administration medication screen dose Have undergone surgery least 2 week prior entry trial Have chemotherapy , immunotherapy , biologic therapy , radio therapy , experimental therapy minimum two week prior medication screen dose participation trial An expect survival minimum 12 week Contraindication nonsteroidal antiinflammatory drug ( NSAIDs ) beta blocker Blood pressure le 100/65 Weight loss 15 % within 2 month prior recruitment Hypersensitivity reaction active component VT122 History myocardial infraction within past 3 month Congestive heart failure ( determine symptom ECG ) AV block second third degree Unstable angina Uncontrolled diabetes Unable assessed grip strength A positive pregnancy test Chronic infection sepsis History bleeding disorder Patients peripheral edema Patients digoxin chronotropic drug Patients evidence severe dehydration Patients evidence ascites</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>NSCLC</keyword>
	<keyword>anorexia</keyword>
	<keyword>cachexia</keyword>
	<keyword>grip strength</keyword>
	<keyword>lean body mass</keyword>
</DOC>